Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",41668,231,1.17 [0.93-1.48],0.1670338993698927
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43096,326,0.96 [0.77-1.19],0.7049261485538576
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42651,2257,1.02 [0.94-1.11],0.5669818131076656
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,43133,697,1.02 [0.88-1.18],0.8231443485910416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,41809,5745,1.02 [0.97-1.07],0.407151269965349
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42015,5216,1.03 [0.97-1.08],0.3141371725466745
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,42716,1991,1.06 [0.97-1.15],0.1985407193640625
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,42980,143,1.00 [0.73-1.38],0.980463655921869
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39770,1549,1.04 [0.94-1.14],0.46460320141539
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38376,1729,1.07 [0.98-1.17],0.1453304067647158
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38269,409,1.09 [0.91-1.31],0.3388568759620307
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30273,3210,1.01 [0.94-1.08],0.7811225853006688
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38017,633,1.10 [0.96-1.27],0.1836857501326633
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43068,2343,1.05 [0.97-1.13],0.2570528559660942
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,43256,820,1.01 [0.88-1.15],0.9129209155317806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,41897,1503,1.02 [0.92-1.13],0.6854630560194719
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43147,1710,1.05 [0.96-1.15],0.3148525886501589
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41053,328,0.96 [0.77-1.19],0.7039475174929606
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43347,77,0.90 [0.57-1.44],0.6629105965533255
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,42930,1493,1.05 [0.95-1.16],0.3174809453348636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42963,126,0.96 [0.67-1.37],0.80369712077144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43202,258,1.08 [0.86-1.36],0.5137297069488465
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43172,228,1.10 [0.86-1.40],0.4534116110688334
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41078,684,1.14 [1.00-1.31],0.0568846894846808
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,40843,449,0.90 [0.74-1.09],0.2965636906707068
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,40890,165,1.16 [0.89-1.52],0.2737424416661166
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43305,90,1.26 [0.88-1.81],0.2108859691173229
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43232,259,1.09 [0.87-1.37],0.4433698858717548
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral warts,43057,84,1.19 [0.82-1.74],0.3582498951788033
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43086,113,0.96 [0.66-1.39],0.8307474475205517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,42856,493,0.89 [0.74-1.07],0.2241094525505965
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43200,100,0.89 [0.58-1.34],0.5660421801273287
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43158,107,0.99 [0.67-1.44],0.9417491952316568
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19867,104,0.59 [0.37-0.93],0.0244165811606384
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",42789,2393,0.96 [0.88-1.04],0.3124210256126937
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of meninges,43321,98,1.30 [0.94-1.79],0.1148025230765167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43233,115,1.18 [0.85-1.63],0.3184374196586586
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43304,175,0.68 [0.48-0.96],0.0286339912202492
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of ovary,23372,146,1.27 [0.97-1.66],0.08591394335153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43304,610,0.98 [0.84-1.15],0.7886063051812322
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Caecum,43313,493,0.95 [0.80-1.14],0.6068272614544407
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43159,116,1.05 [0.74-1.49],0.7807678152996547
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,43307,367,0.99 [0.81-1.22],0.941279138686538
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,43231,582,1.03 [0.88-1.21],0.7151091163422167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43149,1049,1.01 [0.89-1.14],0.9035475190985948
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43297,703,0.90 [0.77-1.05],0.1769727555709542
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Carcinoma in situ of breast,18997,118,1.13 [0.81-1.57],0.4745662018956919
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19065,134,1.02 [0.73-1.42],0.9101506871406864
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34584,91,1.27 [0.90-1.79],0.1735729615886456
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34610,117,1.07 [0.76-1.51],0.6830001958193277
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43258,199,1.15 [0.89-1.47],0.2914667526838923
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",43259,194,1.15 [0.89-1.49],0.2697458635336405
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Leiomyoma of uterus,22591,487,1.21 [1.03-1.41],0.0221007018276456
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lung cancer and mesothelioma,30097,571,0.96 [0.81-1.14],0.6105637704143724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lymphoid leukaemia,34582,89,1.01 [0.67-1.51],0.97754319048475
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34807,314,0.96 [0.77-1.20],0.7282933437793417
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",34824,331,0.80 [0.64-1.02],0.0708262194636066
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19195,164,1.04 [0.78-1.39],0.774279296643321
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34626,133,1.20 [0.90-1.60],0.2234566351838054
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34660,167,0.70 [0.50-1.00],0.048440684806884
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34663,170,1.08 [0.81-1.43],0.6095219256747313
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19159,128,1.08 [0.78-1.49],0.6568398700651663
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34647,154,1.19 [0.90-1.57],0.2250358348754547
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16606,1144,0.94 [0.83-1.06],0.2891687299521974
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34689,196,1.07 [0.82-1.39],0.6407315647287276
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34620,127,0.86 [0.59-1.25],0.4260122458285169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34664,171,0.91 [0.67-1.25],0.5637806620971761
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,43020,345,0.91 [0.73-1.14],0.415465460914072
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of trunk,43280,153,0.89 [0.63-1.24],0.4804840421632996
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanoma in situ,34549,138,1.02 [0.74-1.41],0.8923905127504517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34648,155,1.16 [0.88-1.53],0.2981109151299742
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34760,267,1.09 [0.87-1.36],0.4718928061840424
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",34882,389,0.92 [0.75-1.13],0.4312746814476608
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34658,165,1.06 [0.79-1.41],0.7053656776171531
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,43046,268,1.05 [0.83-1.32],0.6993586148850772
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36266,1773,1.06 [0.97-1.16],0.1640107523610962
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36358,1865,1.07 [0.98-1.16],0.1349598742925993
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42836,571,1.15 [1.00-1.34],0.0562236568879368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40240,146,1.07 [0.78-1.46],0.6843926553522364
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42389,124,0.92 [0.64-1.33],0.6728651961145766
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42034,4750,1.06 [1.00-1.12],0.0479223985913502
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,40964,79,1.04 [0.68-1.60],0.8501530536917349
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,42661,82,0.92 [0.59-1.44],0.7129155478089706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42560,2466,1.04 [0.96-1.12],0.3412684295018653
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42558,2464,1.04 [0.96-1.12],0.3401640355282783
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40238,144,1.16 [0.86-1.56],0.3238228572926359
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,42808,1923,1.08 [1.00-1.18],0.0590751419016693
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,42773,194,1.28 [1.01-1.62],0.0398777999340515
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42370,105,1.00 [0.69-1.47],0.9795847002159944
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42375,110,0.71 [0.46-1.09],0.1152887170282517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43023,444,1.17 [1.00-1.39],0.0572632132755158
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43173,90,0.90 [0.58-1.39],0.6218370200668688
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",42951,372,1.23 [1.03-1.46],0.0190792409210263
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41051,166,1.17 [0.89-1.53],0.2631199330264087
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,33647,504,0.97 [0.82-1.16],0.7509576757617905
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40407,192,0.85 [0.63-1.16],0.3142137930359336
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40426,211,0.78 [0.58-1.04],0.091810159979185
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33236,93,0.81 [0.52-1.26],0.3485024248433701
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40264,103,0.83 [0.55-1.27],0.4000853683156845
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39361,379,1.10 [0.91-1.33],0.3040534210835407
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42588,895,0.99 [0.87-1.13],0.8858558037926328
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42145,452,1.01 [0.84-1.21],0.9103604263834876
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,41870,177,1.23 [0.96-1.58],0.1078635384923063
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,42774,2613,0.92 [0.85-1.00],0.0467384004777982
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,37851,2543,0.92 [0.85-1.00],0.0498377851782912
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33249,106,1.18 [0.84-1.64],0.3454984066017093
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40060,137,0.91 [0.65-1.29],0.6136570075747299
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33593,450,1.04 [0.87-1.24],0.6519561556891047
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33246,103,0.82 [0.54-1.24],0.3419179638503107
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39028,5885,0.98 [0.93-1.03],0.4979556676756242
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33470,327,1.05 [0.85-1.29],0.6528518573371175
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34056,913,1.05 [0.93-1.19],0.4392706245069253
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43219,524,1.13 [0.96-1.32],0.1311725467870765
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,42903,208,1.12 [0.87-1.43],0.3830565947776451
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33352,209,1.11 [0.86-1.43],0.4192451061830126
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33243,100,1.44 [1.09-1.91],0.0111312795140147
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42447,2524,0.99 [0.92-1.07],0.7997808355515532
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33554,411,1.05 [0.88-1.27],0.57664534794291
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33590,447,1.12 [0.95-1.33],0.1889168641518572
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34196,1053,1.02 [0.91-1.15],0.7605780110651095
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33320,177,1.03 [0.78-1.38],0.8171868671005746
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,42891,196,1.11 [0.86-1.44],0.4081826569640071
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34131,988,0.98 [0.87-1.11],0.7795665681022093
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,33948,805,1.07 [0.94-1.22],0.2841027267561863
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39090,108,1.44 [1.08-1.91],0.0123207299098872
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41441,8298,0.99 [0.95-1.04],0.7262397785261765
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,39996,73,0.71 [0.41-1.20],0.1987863495191848
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40020,97,0.81 [0.52-1.26],0.3468736865854207
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43046,3222,1.00 [0.94-1.07],0.9361095295294428
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43048,3218,1.00 [0.94-1.08],0.9101478333955076
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40007,84,0.94 [0.61-1.47],0.8002650322074698
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,42772,2024,1.04 [0.96-1.13],0.3671107962970593
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",35720,2577,1.02 [0.94-1.10],0.6722556481322837
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43328,346,1.04 [0.85-1.28],0.7048117318959197
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,41816,123,1.11 [0.80-1.55],0.5425512311098784
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,40927,179,0.95 [0.70-1.28],0.7340045203771932
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,40987,239,0.92 [0.71-1.20],0.5336106050616602
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33415,272,1.12 [0.90-1.39],0.3139009105901066
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39468,258,0.97 [0.76-1.23],0.7761621165630657
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3549,140,1.35 [1.04-1.77],0.0266232003762262
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3781,416,0.83 [0.67-1.03],0.0912510179952331
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39312,102,0.78 [0.51-1.20],0.2611912910109268
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3486,78,1.37 [0.94-1.99],0.098379901106783
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42308,3098,0.90 [0.83-0.96],0.0035164696118862
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42253,560,1.06 [0.91-1.24],0.4656602426061521
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39590,608,0.98 [0.83-1.16],0.820374671893317
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34362,1219,1.02 [0.91-1.14],0.7326748993632418
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43160,411,1.01 [0.84-1.22],0.907130076346291
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41460,271,1.15 [0.93-1.43],0.1955666043377327
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,39652,1967,1.03 [0.95-1.12],0.4902220842345396
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,41588,399,1.16 [0.97-1.39],0.0944833463283734
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41285,96,1.15 [0.79-1.66],0.4760195683327349
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41517,328,1.11 [0.91-1.36],0.2974973526613541
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,26888,3125,1.01 [0.94-1.09],0.7350270009800574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,AV-block,36646,701,1.03 [0.89-1.19],0.6911249059965482
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43247,681,1.05 [0.91-1.22],0.4716436607369907
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,24079,316,1.21 [0.99-1.48],0.0631206505334229
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36232,287,0.92 [0.72-1.17],0.4857275819213631
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36105,160,0.89 [0.64-1.24],0.4993021889670794
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43345,77,1.07 [0.70-1.63],0.7509382861503522
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,37654,1709,0.98 [0.89-1.07],0.6101741982221077
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41112,3459,1.06 [1.00-1.14],0.0545610096077505
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,37946,12735,1.01 [0.98-1.05],0.4934762298008716
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41053,443,1.04 [0.87-1.25],0.6779626225565836
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Endocarditis,36061,116,1.20 [0.87-1.65],0.2717429772482401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",42995,1791,1.05 [0.96-1.14],0.3113691848468572
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,39462,10897,1.01 [0.97-1.05],0.5674679452527033
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39474,10909,1.01 [0.97-1.05],0.5899590861273847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43054,128,1.23 [0.91-1.64],0.1741732079261983
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28876,311,1.09 [0.89-1.33],0.4068079904968582
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28727,162,1.17 [0.89-1.52],0.2580176588189815
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,43114,1880,1.00 [0.92-1.10],0.9452554493165756
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,41825,179,0.94 [0.69-1.27],0.6702917693870658
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41396,3711,1.05 [0.99-1.12],0.1030378455170326
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42740,936,0.92 [0.81-1.05],0.2400694838739244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36536,591,0.92 [0.78-1.09],0.3321345402675169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42571,1394,1.06 [0.96-1.17],0.2757645029551969
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38857,1172,1.07 [0.96-1.20],0.2134809021404357
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43186,264,1.10 [0.88-1.39],0.3991968781362452
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43296,512,1.12 [0.96-1.32],0.1500802353563763
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,40699,89,1.23 [0.86-1.75],0.2601854537110162
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other aneurysm,41317,128,1.17 [0.86-1.60],0.3239731976961129
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,36654,709,0.98 [0.85-1.14],0.8043629494765996
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41357,168,1.08 [0.81-1.45],0.5880574037577546
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41584,395,1.07 [0.88-1.29],0.4998005089074274
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36242,297,0.96 [0.76-1.21],0.7068146151698493
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,40757,147,0.97 [0.70-1.35],0.8627445088970036
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,40693,83,1.57 [1.16-2.13],0.0039528378469852
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,40975,104,0.97 [0.66-1.42],0.8627261687864473
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,40829,219,1.01 [0.77-1.31],0.9605377249217876
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37631,1686,1.04 [0.95-1.14],0.3938521707121012
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41323,89,1.14 [0.78-1.66],0.50251696380577
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42088,899,1.07 [0.94-1.21],0.324054954034402
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42318,584,1.09 [0.93-1.26],0.2777330255171092
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",41871,1000,1.06 [0.94-1.19],0.3562989937183057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24319,556,1.13 [0.97-1.33],0.1230322603449094
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41801,663,1.09 [0.94-1.25],0.2586827659433282
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41180,570,1.04 [0.88-1.22],0.65960217307986
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42513,779,1.10 [0.96-1.25],0.1725162790609741
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43224,1065,0.97 [0.86-1.10],0.649205826086034
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36509,564,0.97 [0.82-1.14],0.702036751928907
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42311,577,1.09 [0.94-1.27],0.2604584674380968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41188,317,0.98 [0.78-1.22],0.8427363597122922
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42718,1072,0.92 [0.82-1.05],0.2078156083933637
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42685,1135,0.93 [0.82-1.04],0.206089910556699
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,41780,97,0.74 [0.47-1.16],0.1914917936721123
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41318,130,1.14 [0.83-1.57],0.4076104759036155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42174,370,0.86 [0.69-1.07],0.1833348657293075
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41607,430,1.06 [0.88-1.27],0.5415160213553354
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,41292,682,1.07 [0.93-1.24],0.3326146038370604
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41215,144,0.61 [0.42-0.90],0.0132547402917707
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42961,1229,1.06 [0.96-1.18],0.2631983629326395
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43134,602,0.84 [0.71-1.00],0.0548167740558697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",37966,2385,1.02 [0.95-1.10],0.5833945486333653
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,42253,6672,0.97 [0.92-1.01],0.1712472808885481
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43054,704,0.85 [0.73-1.00],0.0477311595804841
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38242,2661,0.92 [0.85-0.99],0.0323780812756698
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35716,135,1.10 [0.80-1.51],0.576421471584752
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,42441,2305,0.96 [0.89-1.04],0.3090638129683448
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38312,2731,0.94 [0.87-1.02],0.1436763615807713
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Vascular dementia,42543,211,0.95 [0.72-1.25],0.717064388547396
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Alzheimer disease,43345,561,0.98 [0.83-1.15],0.794072639565866
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",29383,101,1.23 [0.90-1.70],0.1992489071836029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Bell's palsy,40365,138,1.24 [0.94-1.66],0.132182307209165
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41067,840,0.97 [0.84-1.11],0.6419804405934575
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral cysts,42675,383,1.03 [0.85-1.25],0.7561766868426975
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43210,518,0.99 [0.84-1.18],0.9539274616364166
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42532,93,1.23 [0.87-1.75],0.2340799261225173
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43320,102,1.29 [0.94-1.77],0.1122077844518029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42413,121,0.97 [0.68-1.39],0.8735095601002782
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,40781,467,0.82 [0.67-1.00],0.0501133979656118
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42542,2228,0.95 [0.87-1.03],0.2408879702573077
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43271,695,0.97 [0.83-1.12],0.6676101659727123
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42351,4229,0.99 [0.93-1.05],0.6840701533459501
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,42723,93,0.80 [0.51-1.26],0.3430150520998899
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,43099,407,1.05 [0.87-1.27],0.5941299890637329
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hydrocephalus,42393,101,0.90 [0.59-1.36],0.6081833790956939
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43311,116,1.29 [0.96-1.74],0.0963558520968719
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40357,130,0.96 [0.68-1.36],0.8126299821854928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40362,135,1.22 [0.90-1.64],0.1993346345241968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Memory loss,42298,192,0.83 [0.61-1.12],0.2247573939290106
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,40904,590,1.06 [0.91-1.24],0.4295342272753204
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43229,538,1.05 [0.89-1.23],0.5811145609234403
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Motor neuron disease,29570,252,1.07 [0.85-1.35],0.5681634084767255
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43047,176,1.04 [0.78-1.39],0.7910096766844046
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42229,2002,1.03 [0.95-1.13],0.4285743643891939
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,40846,6075,0.99 [0.94-1.04],0.7251413983022539
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,42739,300,1.09 [0.88-1.34],0.4433885136218085
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40892,665,1.08 [0.93-1.25],0.2979039916421966
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43218,481,0.96 [0.80-1.15],0.6521312879701218
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34680,1067,1.05 [0.94-1.18],0.3990903767779672
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42410,118,0.64 [0.42-0.98],0.0416081760446117
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42525,233,0.98 [0.76-1.26],0.8642231324454088
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,42827,251,1.07 [0.85-1.35],0.5839329789184449
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40389,162,1.24 [0.95-1.62],0.1125302717112605
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other headache syndromes,40414,100,0.81 [0.53-1.25],0.3513370921681152
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,43148,856,0.96 [0.84-1.10],0.5430123101150042
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,41225,911,0.99 [0.87-1.13],0.8445529838045611
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Parkinson's disease,43303,408,0.91 [0.74-1.11],0.3359914746501835
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42384,92,1.08 [0.73-1.59],0.7049695650042774
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,43343,112,0.99 [0.68-1.42],0.947915005447096
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,42948,789,0.98 [0.85-1.13],0.7832087524069764
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,42817,80,1.18 [0.80-1.73],0.3953155657824019
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43318,298,1.06 [0.85-1.32],0.5933465762627308
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40316,89,1.37 [1.00-1.89],0.0530466381462039
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43345,567,1.00 [0.85-1.17],0.9962660653385867
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42476,204,0.94 [0.72-1.25],0.6884546562484015
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42394,162,0.99 [0.73-1.34],0.9641444364859562
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,42668,663,0.96 [0.82-1.12],0.6174822116420844
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43071,390,0.78 [0.63-0.98],0.0315850977397913
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,41673,91,1.12 [0.77-1.63],0.5488707497592424
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41681,99,0.95 [0.63-1.43],0.7992277236646703
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43163,92,0.99 [0.66-1.48],0.943895193844308
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,42918,249,1.01 [0.79-1.29],0.9649315280690336
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3493,84,1.34 [0.94-1.92],0.1096660301830232
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4235,161,1.32 [1.02-1.70],0.0330597581199608
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42396,164,0.88 [0.64-1.22],0.4560837350675261
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43006,1729,0.92 [0.84-1.02],0.1040148537717342
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42724,1142,1.07 [0.96-1.19],0.2530114869369779
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41956,374,1.13 [0.94-1.36],0.1976693666590852
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43213,1208,0.96 [0.85-1.07],0.453885526214564
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43331,117,1.21 [0.88-1.66],0.2319484895111109
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43093,1088,0.98 [0.87-1.10],0.7192368139347104
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43274,605,1.05 [0.90-1.22],0.5509557783940838
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43186,300,1.01 [0.81-1.27],0.915069667969386
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,41680,98,1.27 [0.92-1.75],0.1412823464369464
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,41693,111,0.94 [0.64-1.38],0.7471899670698237
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,41678,96,0.99 [0.67-1.47],0.9674139261137774
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43193,1182,0.97 [0.86-1.08],0.5581135878580734
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42319,308,1.05 [0.85-1.30],0.6260194937588497
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42082,77,0.76 [0.46-1.26],0.2855050020122738
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,42834,165,1.02 [0.76-1.37],0.8898689415694128
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43122,453,1.06 [0.89-1.27],0.4968143608583637
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42331,326,1.13 [0.92-1.38],0.2340916444062962
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43063,177,1.13 [0.86-1.48],0.3868894054491476
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42784,773,0.91 [0.79-1.05],0.2062985085794465
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42465,233,1.04 [0.81-1.33],0.7848026290450738
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,40707,3649,1.02 [0.96-1.09],0.4546154010507817
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43067,398,1.04 [0.86-1.26],0.6789888753359586
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43308,259,1.14 [0.92-1.42],0.2340729833239546
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42257,675,1.15 [1.01-1.32],0.0384540041665409
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,42780,111,1.34 [1.01-1.79],0.0450601341235052
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43308,94,1.18 [0.82-1.69],0.3701958693145524
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,41726,144,1.25 [0.96-1.64],0.1039392913972657
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41832,250,1.16 [0.93-1.45],0.1851957623009999
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41470,193,0.93 [0.70-1.25],0.6334684369726855
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42101,96,0.73 [0.47-1.16],0.1822721609081247
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41388,111,1.10 [0.78-1.56],0.5879521911047226
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42155,144,0.74 [0.51-1.07],0.1041931802908523
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42332,321,0.96 [0.77-1.19],0.6853057087545272
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,41784,202,0.99 [0.75-1.30],0.94900292202479
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41458,181,0.84 [0.61-1.15],0.2714267328409492
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41410,133,1.14 [0.84-1.56],0.394570496849588
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40025,2967,0.95 [0.88-1.02],0.1349732307886048
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,41707,125,1.28 [0.96-1.71],0.0973202844636001
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42919,687,0.98 [0.84-1.14],0.7768548918714813
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42326,94,0.90 [0.59-1.38],0.629343302665514
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42497,265,0.93 [0.73-1.19],0.5772616008052445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,42972,146,0.91 [0.65-1.27],0.5642986398215804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43272,197,1.24 [0.98-1.57],0.0785686638469329
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43130,220,0.84 [0.63-1.12],0.2257551431550886
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,42931,105,0.90 [0.60-1.34],0.6014121105238915
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,42933,107,1.26 [0.92-1.73],0.155107845579858
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43167,1461,1.05 [0.95-1.16],0.3373537765528686
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,42752,1046,1.10 [0.98-1.23],0.0944094030008484
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,41913,207,0.98 [0.75-1.29],0.8905196809758529
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,41848,142,1.08 [0.79-1.48],0.611928303582885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,42926,120,0.94 [0.65-1.36],0.7476313678295512
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43165,359,0.83 [0.66-1.04],0.0985000657791654
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,42912,106,0.77 [0.51-1.18],0.2349109279707895
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza,40056,188,0.88 [0.65-1.19],0.4094804618899603
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40053,185,0.87 [0.64-1.18],0.368285192711934
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),29727,201,1.08 [0.83-1.40],0.5562443632705629
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,43140,477,1.05 [0.88-1.25],0.5843501631609327
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32081,2998,1.02 [0.96-1.10],0.4969018392259156
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32480,2954,1.02 [0.95-1.09],0.6006114591102947
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),42670,230,0.97 [0.75-1.26],0.8282692900959323
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40002,134,0.95 [0.67-1.34],0.759699561988228
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bronchiectasis,37521,580,0.97 [0.82-1.14],0.6830465288917458
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37035,94,1.12 [0.77-1.63],0.5520105266071549
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,41638,4697,1.02 [0.97-1.08],0.4682162047122499
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41016,126,1.09 [0.78-1.52],0.6105841483275811
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,41145,255,1.10 [0.87-1.38],0.4392268272244607
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43016,1970,1.00 [0.92-1.10],0.9398105531202896
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,41076,186,0.83 [0.61-1.14],0.2435705336095919
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,39854,8759,1.01 [0.97-1.06],0.5094349840947532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41519,629,0.85 [0.72-1.01],0.0682417777999105
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,41596,550,1.10 [0.94-1.29],0.2547408653951505
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Emphysema,37463,522,1.07 [0.91-1.26],0.4247006942386009
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41106,488,0.88 [0.73-1.06],0.170919627875522
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,42967,3099,0.95 [0.88-1.02],0.1575047515965942
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,41163,545,0.93 [0.78-1.10],0.4005131800431154
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Later onset COPD,41623,1420,0.96 [0.87-1.07],0.4777784019833028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43324,515,0.98 [0.82-1.16],0.8151150603699786
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,41074,184,1.19 [0.92-1.54],0.1897959637138058
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,42913,1598,1.04 [0.94-1.14],0.455603253549683
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,42945,3311,0.99 [0.92-1.06],0.7531693360507712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42313,1423,0.99 [0.89-1.10],0.8325614492901778
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other pleural conditions,39718,84,0.98 [0.64-1.50],0.9136540585121896
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43182,674,0.94 [0.81-1.10],0.4601290908159232
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43160,2174,0.95 [0.87-1.04],0.2642242409625643
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,41259,1625,1.00 [0.91-1.10],0.9706190161146154
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural plaque,39895,261,1.03 [0.82-1.31],0.7827640289312279
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42549,2681,0.97 [0.90-1.05],0.4891223051885188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43212,403,1.03 [0.85-1.25],0.7307424032577714
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumothorax,39837,203,0.96 [0.72-1.27],0.7593121469168853
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pollen allergy,43307,406,1.05 [0.87-1.27],0.6233478527466454
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,42617,109,1.02 [0.71-1.47],0.9075153402071024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29617,91,1.07 [0.72-1.57],0.7506915740165718
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,42879,1564,1.05 [0.95-1.15],0.333550915435749
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41368,478,1.04 [0.88-1.24],0.6253620253002696
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Viral pneumonia,40272,404,0.80 [0.65-1.00],0.0467134014850468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",42700,332,0.80 [0.63-1.01],0.061067926241638
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20024,187,0.87 [0.64-1.19],0.3923123157676371
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30709,106,0.77 [0.50-1.18],0.2302808669610397
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,43070,239,1.15 [0.91-1.44],0.2442709252291585
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute gastritis,32686,140,1.30 [1.00-1.70],0.0507981744512359
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,40271,309,0.96 [0.77-1.20],0.7340802907928188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute peritonitis,42554,150,1.15 [0.86-1.53],0.3501770877903841
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,41859,122,1.35 [1.01-1.79],0.0414732821387986
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,33269,723,1.14 [1.00-1.30],0.0447698145522565
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40128,166,1.27 [0.99-1.63],0.061464040853632
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",42647,166,1.27 [0.99-1.64],0.0594940104963059
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,40292,330,0.93 [0.75-1.16],0.5262807202414942
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,41649,1687,0.99 [0.90-1.08],0.7770832015934038
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,33046,500,1.06 [0.90-1.26],0.4655519124524118
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40042,80,0.98 [0.63-1.52],0.914914863979072
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43106,180,0.99 [0.74-1.32],0.926835488509048
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,40658,199,1.30 [1.04-1.63],0.0226964455850742
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Collagenous colitis,40515,135,1.30 [0.99-1.72],0.0608030073378296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43078,323,1.05 [0.85-1.30],0.632483976980124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,42916,2736,1.03 [0.96-1.11],0.4212651997826169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,40526,146,1.00 [0.73-1.38],0.9875110766054244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42746,102,0.98 [0.66-1.44],0.9149378635402836
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40516,136,0.95 [0.68-1.34],0.7839734408348267
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,42100,388,1.08 [0.89-1.31],0.4398399882713414
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,38941,3703,1.02 [0.96-1.08],0.5671726164869082
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,43133,302,1.12 [0.91-1.38],0.2762079761820911
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,43144,1407,1.03 [0.93-1.14],0.6177544901936203
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",39709,7163,1.03 [0.99-1.08],0.1675885667087934
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42633,921,1.00 [0.88-1.14],0.9934429408998235
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43198,794,0.98 [0.85-1.12],0.7266242493231354
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41903,191,1.02 [0.77-1.35],0.8904942561045195
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,41661,104,0.81 [0.53-1.24],0.3309264909431775
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,42821,2362,1.06 [0.98-1.14],0.16859492398686
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of tongue,41679,187,1.00 [0.75-1.33],0.9963800377264982
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42321,2359,1.01 [0.93-1.09],0.8527010860976312
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,35897,5294,1.08 [1.03-1.14],0.0026575815004269
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,32874,328,1.02 [0.82-1.26],0.8859026398596073
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43196,261,1.04 [0.82-1.32],0.738207163246983
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43201,89,1.16 [0.80-1.69],0.43259113109292
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,41954,217,0.98 [0.76-1.28],0.8974331938574275
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30852,249,1.13 [0.90-1.43],0.2943525575471487
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,33467,921,0.89 [0.77-1.02],0.0902776518421048
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,33152,606,1.08 [0.93-1.26],0.2916040573500991
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,36720,4174,1.01 [0.95-1.07],0.8485831628444193
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33444,898,1.05 [0.93-1.19],0.4231931265731804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33574,13828,1.02 [0.98-1.05],0.2902877808863964
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,42380,1921,1.04 [0.95-1.13],0.4349583554100363
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,41818,106,0.82 [0.54-1.24],0.3421686877982662
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32221,2095,1.03 [0.94-1.12],0.566404056024058
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",41842,105,1.29 [0.94-1.78],0.1161837591424879
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,40621,5383,0.98 [0.93-1.03],0.3863372945776652
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,43212,83,1.21 [0.83-1.76],0.3309414641041883
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impaction of intestines,30698,95,0.95 [0.62-1.44],0.7939583678493964
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,36738,1500,0.92 [0.83-1.02],0.1068283728199055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35407,169,0.83 [0.60-1.15],0.2651156201630314
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,30762,159,1.03 [0.76-1.41],0.8403383507632746
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40697,238,1.25 [1.01-1.55],0.041898457309414
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31538,935,1.08 [0.95-1.22],0.240540240479505
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43301,603,0.94 [0.80-1.11],0.4694816405194673
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41643,1263,1.07 [0.97-1.19],0.1934538369864146
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42059,1679,1.06 [0.97-1.17],0.1790737681873514
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32855,309,1.07 [0.86-1.32],0.5449893695043981
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,33558,1012,1.08 [0.96-1.21],0.1946511184108578
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43255,229,1.10 [0.87-1.41],0.4206410145640173
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35351,113,0.69 [0.45-1.05],0.0863931260276651
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32874,2271,1.12 [1.03-1.21],0.0049357608509273
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40424,462,1.13 [0.95-1.33],0.1646743853130518
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40223,261,0.88 [0.68-1.13],0.3141640434548405
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,33539,2936,1.05 [0.98-1.13],0.1887532955930899
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,39987,9384,1.04 [1.00-1.08],0.0425054192697496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41644,349,0.94 [0.76-1.17],0.579773443471127
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,42877,1140,1.02 [0.91-1.14],0.7072595752778839
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33648,1102,1.14 [1.02-1.27],0.0177535731027135
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40207,245,1.15 [0.92-1.44],0.2257185251949433
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43089,685,0.92 [0.79-1.08],0.2991087665127258
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34125,1579,1.11 [1.01-1.21],0.0283316258265153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42406,1947,1.04 [0.95-1.13],0.379088625225167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42002,290,1.18 [0.96-1.46],0.1056544586477939
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33421,2818,1.05 [0.97-1.13],0.2058548124326293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),35883,3337,1.04 [0.97-1.11],0.231582910005968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,41900,163,1.00 [0.74-1.35],0.9824035761611474
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41858,1478,1.09 [0.99-1.20],0.0701756271530288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31169,566,1.00 [0.85-1.18],0.9863892124482484
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43183,103,1.11 [0.77-1.59],0.5753552596112179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31412,809,1.01 [0.88-1.16],0.9124256211485158
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40715,256,0.93 [0.72-1.20],0.5704096065751547
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43323,100,0.84 [0.55-1.28],0.4053768993983159
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,41718,201,0.91 [0.68-1.21],0.5032154088237919
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Toxic colitis,40472,92,0.91 [0.60-1.39],0.6758069301056258
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33000,454,1.11 [0.93-1.31],0.2513455495385994
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,40648,268,0.96 [0.76-1.23],0.7578695774843353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40604,224,0.96 [0.73-1.25],0.7440294491238172
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,35690,452,0.94 [0.78-1.14],0.5191016209675401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,30898,295,1.02 [0.81-1.28],0.8647883865327666
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,35662,424,0.93 [0.76-1.13],0.4535091482040427
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Volvulus,30736,133,0.70 [0.47-1.03],0.0733596923393532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43218,474,1.18 [1.01-1.38],0.0424413461705882
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,42812,133,0.87 [0.61-1.24],0.4389715057095075
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39970,270,1.14 [0.92-1.41],0.2431507339728758
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42247,1162,0.91 [0.81-1.02],0.116915358784978
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41386,301,1.02 [0.81-1.28],0.8687520410203461
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40340,640,0.95 [0.81-1.11],0.5087515940980851
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,42831,462,0.99 [0.83-1.19],0.9299490599078072
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43166,797,1.05 [0.92-1.20],0.506861261835792
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42448,79,0.87 [0.55-1.39],0.5633633662757731
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,40703,5301,1.03 [0.98-1.09],0.2400766837006814
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42567,737,1.14 [1.00-1.30],0.0532970656531054
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42346,516,1.11 [0.94-1.30],0.2103389624541738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42668,1583,0.94 [0.85-1.04],0.231010412016208
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43317,89,1.14 [0.78-1.66],0.5105146945377675
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,39809,109,1.28 [0.94-1.75],0.1218518146228007
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41916,86,1.29 [0.92-1.81],0.1449832241648884
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,42813,444,0.99 [0.83-1.20],0.947361228073636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40449,749,1.05 [0.92-1.21],0.4543069207892617
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,39808,108,1.02 [0.71-1.48],0.9075736142270908
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43197,132,1.23 [0.92-1.65],0.167652041551143
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41386,301,1.09 [0.89-1.35],0.4029923723615282
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43003,324,0.97 [0.78-1.20],0.7700184121621712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42465,96,1.15 [0.81-1.65],0.4341849286727443
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,39803,103,0.81 [0.53-1.24],0.3274504790855835
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42372,2672,1.03 [0.96-1.11],0.3699223042732472
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40517,817,1.04 [0.91-1.19],0.5314392300898817
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,39815,115,1.00 [0.70-1.44],0.992992112851091
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43197,518,0.99 [0.83-1.17],0.874101265208006
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42488,119,1.24 [0.92-1.69],0.1623368087062452
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43105,426,0.94 [0.78-1.14],0.5402059617833099
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43260,516,1.18 [1.01-1.37],0.0313567453433259
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39916,216,0.99 [0.76-1.29],0.9572949230002508
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40143,443,1.03 [0.86-1.23],0.7804530814125061
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43243,499,1.20 [1.03-1.39],0.0192641997834443
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40078,378,1.06 [0.88-1.29],0.5226436192088741
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43290,225,1.21 [0.97-1.52],0.0931410551797732
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37184,179,0.88 [0.64-1.20],0.4052759243812542
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39437,9431,0.99 [0.95-1.03],0.5612972003095766
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37077,7071,0.98 [0.94-1.03],0.3852374997634394
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37132,127,1.18 [0.86-1.62],0.2954778347711344
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37642,251,1.07 [0.84-1.36],0.5723199459659314
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37684,293,1.07 [0.86-1.33],0.5666168769759405
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,42924,152,0.97 [0.70-1.34],0.8395126014741581
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37554,163,1.00 [0.74-1.36],0.98360593961099
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,31918,1912,0.93 [0.85-1.02],0.1390601514508455
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43109,322,0.95 [0.76-1.18],0.623753344968579
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38111,720,0.92 [0.79-1.07],0.2564973764179304
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36637,12147,1.01 [0.98-1.05],0.5207067775294675
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40037,194,0.87 [0.65-1.18],0.3698428522054765
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37255,250,1.03 [0.81-1.32],0.8084288405333813
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37968,963,1.09 [0.97-1.23],0.1535589810962629
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,41783,4392,0.99 [0.94-1.05],0.8625966361631431
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37469,464,1.14 [0.96-1.34],0.1319204661794665
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37389,384,0.97 [0.79-1.19],0.7750008618660258
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37242,237,0.84 [0.64-1.11],0.2138955050806425
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42229,120,1.06 [0.75-1.49],0.7402342207025188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,32823,2817,1.01 [0.94-1.09],0.7364815856665285
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30972,966,1.05 [0.93-1.18],0.4617353715349119
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43213,950,1.08 [0.95-1.21],0.2325751394568626
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30136,130,0.95 [0.67-1.34],0.762916701381769
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30569,563,0.95 [0.81-1.13],0.570874649333805
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37510,505,1.06 [0.90-1.26],0.4679568033775819
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31082,1076,1.05 [0.93-1.18],0.4354293563902709
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37481,90,0.75 [0.47-1.19],0.2250208588473337
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38433,1042,0.96 [0.85-1.09],0.5516994950733853
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37892,501,1.08 [0.91-1.27],0.3821739296747566
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31005,999,1.05 [0.93-1.19],0.3949110772451012
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37134,129,0.98 [0.69-1.39],0.919905611007891
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37105,100,1.06 [0.72-1.54],0.7786558020535879
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,39959,116,1.08 [0.77-1.52],0.643624799290115
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,42700,2857,1.01 [0.94-1.09],0.7534674078078989
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41720,1877,1.02 [0.93-1.11],0.6807740869890591
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43102,759,1.04 [0.91-1.20],0.5519209251054102
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34168,4162,0.97 [0.92-1.04],0.3979202090900147
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30113,107,0.67 [0.43-1.04],0.0742241505351548
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37159,154,1.33 [1.03-1.72],0.02750943538741
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30097,91,0.82 [0.53-1.28],0.3822536077678188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30220,214,1.06 [0.83-1.37],0.6269617240877429
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40255,412,0.90 [0.73-1.10],0.2863743679244138
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40462,619,1.08 [0.93-1.25],0.2896982189375078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43295,163,0.91 [0.66-1.26],0.5779508025608451
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40377,2986,0.99 [0.92-1.06],0.8011351262735545
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37172,167,1.07 [0.79-1.43],0.6735705576615487
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30239,233,1.12 [0.89-1.40],0.349218195667982
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38598,1207,0.98 [0.88-1.10],0.7595879586535672
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33629,3623,1.01 [0.95-1.08],0.6833400916063757
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42266,157,1.11 [0.83-1.48],0.4813244813305106
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43313,127,0.84 [0.58-1.23],0.373385701164684
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37140,135,1.17 [0.87-1.59],0.3049038695138975
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39070,2065,1.04 [0.96-1.13],0.316716472446692
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37152,147,0.90 [0.64-1.27],0.5449887571708993
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,32717,2711,1.02 [0.95-1.10],0.6065638857756012
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40043,200,0.78 [0.57-1.07],0.1190318104154868
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37089,84,1.25 [0.87-1.80],0.2183137660254072
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37656,265,0.98 [0.77-1.24],0.8457694489765476
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37901,896,1.11 [0.98-1.25],0.1003696869888705
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42707,598,1.08 [0.93-1.26],0.2934954856605788
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38336,945,1.03 [0.91-1.16],0.6627512983284052
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43123,740,1.06 [0.92-1.21],0.4327126157414825
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43308,91,0.93 [0.61-1.42],0.737490378767981
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37326,321,1.21 [1.00-1.46],0.0557772841391661
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34311,1255,1.01 [0.90-1.12],0.880907229042079
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37959,954,1.05 [0.93-1.19],0.3969230582154793
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37392,387,1.12 [0.93-1.35],0.2254056628307812
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30100,94,1.14 [0.80-1.64],0.4569907981151204
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34142,4136,1.01 [0.95-1.07],0.7372640160231507
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31089,1083,1.02 [0.91-1.15],0.7032965495712222
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42490,381,1.10 [0.91-1.32],0.3203936538941388
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43235,103,1.10 [0.77-1.57],0.6096666459109603
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",39734,84,0.97 [0.63-1.49],0.8837712988367917
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30136,130,0.84 [0.58-1.22],0.3607609741505048
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37562,171,0.94 [0.69-1.28],0.7028151526817858
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30776,770,1.04 [0.91-1.19],0.5633212051273913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37524,519,1.06 [0.90-1.25],0.4821496309986298
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37823,432,0.99 [0.82-1.19],0.8963655614153779
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37696,305,1.02 [0.82-1.27],0.8498536767764464
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,33899,100,0.82 [0.54-1.26],0.3741232162499742
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43315,98,0.94 [0.63-1.41],0.7808416848723667
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37986,981,1.03 [0.91-1.17],0.6073184729816082
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],42272,163,1.17 [0.89-1.54],0.2611536836909062
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41307,4302,1.05 [0.99-1.11],0.0817342574196022
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37229,224,0.98 [0.76-1.28],0.9022841695317956
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38269,878,1.01 [0.89-1.15],0.8677707975298422
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,40942,390,1.01 [0.83-1.22],0.9479628150761428
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,37720,329,0.99 [0.80-1.22],0.8958510681372551
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,39938,2547,1.01 [0.94-1.09],0.7916615331454693
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39051,1660,1.04 [0.95-1.14],0.3652348200172906
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37091,86,1.51 [1.11-2.04],0.0076926204938104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42355,246,1.32 [1.08-1.62],0.0065293915054419
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37281,276,1.23 [1.01-1.50],0.0435278395638617
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37139,134,1.17 [0.86-1.58],0.3150594678090039
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30099,93,0.90 [0.59-1.39],0.6438560999635956
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,41784,2491,1.08 [1.00-1.16],0.0445696275852501
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17561,87,1.44 [1.05-1.97],0.0222020283575608
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22849,97,1.12 [0.77-1.62],0.5494682115714353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42823,531,0.97 [0.82-1.15],0.7375832605979595
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42435,143,1.17 [0.87-1.56],0.303347436612976
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41556,2263,1.13 [1.05-1.22],0.0009120215001695
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43008,104,1.37 [1.03-1.83],0.0323887046166322
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,42978,491,1.06 [0.89-1.25],0.5186212373194574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,38267,388,0.92 [0.75-1.13],0.4477525216427561
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dialysis,39403,110,1.65 [1.30-2.08],3.464627845938921e-05
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18860,2758,1.07 [0.99-1.15],0.0719552449939563
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23025,273,0.94 [0.74-1.20],0.61343230483195
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,17623,149,1.30 [1.00-1.69],0.0499464557896238
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17808,334,1.02 [0.83-1.26],0.8273787040958194
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18338,864,1.03 [0.91-1.17],0.6480394528217968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36234,8817,1.04 [1.00-1.08],0.0768464609280737
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43027,123,1.19 [0.87-1.63],0.2741738058550663
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,16273,171,1.02 [0.75-1.38],0.9005627549685501
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39247,467,0.96 [0.80-1.15],0.6661155191741555
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18267,2165,1.06 [0.98-1.15],0.1591147640014229
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22963,347,0.98 [0.79-1.21],0.8391823341357297
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16297,195,0.99 [0.74-1.32],0.9441049676156849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,23046,107,0.98 [0.67-1.44],0.9306932818732582
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17735,261,1.02 [0.80-1.29],0.886638456910176
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38007,128,0.94 [0.66-1.34],0.7303605665371837
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19554,2080,1.01 [0.93-1.10],0.8064608806804554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16200,98,1.27 [0.90-1.80],0.1707635273104666
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17590,116,0.95 [0.65-1.38],0.7746699595229828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43330,108,0.75 [0.49-1.15],0.1844171552834638
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43328,108,1.03 [0.72-1.49],0.8644678083950963
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41597,3718,0.99 [0.93-1.06],0.8254728971383616
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39093,1214,1.00 [0.90-1.12],0.933987770386063
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22847,95,0.94 [0.63-1.42],0.7700955913359535
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43237,750,1.08 [0.95-1.24],0.2477339205650799
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16357,255,1.21 [0.97-1.51],0.0892933847916698
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16339,237,1.01 [0.79-1.31],0.9114916707381192
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16290,188,1.02 [0.76-1.35],0.9125955309568043
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43283,114,1.05 [0.74-1.49],0.7796887106586103
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40716,2837,0.99 [0.92-1.07],0.8114472003852732
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22794,178,0.89 [0.65-1.21],0.4630050878479078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17607,133,1.11 [0.81-1.52],0.5051194576410507
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17803,329,1.07 [0.87-1.32],0.5262665070903124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17574,100,1.00 [0.68-1.47],0.985758896033443
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17650,176,0.78 [0.56-1.09],0.1477339991846065
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39327,547,1.03 [0.87-1.21],0.7277080489766292
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,42733,246,1.06 [0.84-1.35],0.612440923922557
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17737,263,1.04 [0.83-1.32],0.7144582861140532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17562,88,0.76 [0.47-1.21],0.2402656957911169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18013,539,1.24 [1.08-1.43],0.0031237045928477
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17612,138,0.82 [0.57-1.18],0.2833615898541597
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17968,494,1.02 [0.85-1.21],0.8607743247753008
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,42990,86,1.04 [0.69-1.57],0.8370937712643456
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16320,218,0.89 [0.67-1.18],0.4292873952924222
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,42984,4204,1.08 [1.02-1.14],0.0068746321955714
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",38974,194,1.25 [0.98-1.58],0.0667944379414217
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39487,194,1.19 [0.93-1.52],0.1665764921498557
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42388,96,0.96 [0.63-1.44],0.8368576046850011
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38251,372,1.01 [0.83-1.24],0.9122020475834384
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42956,664,1.00 [0.86-1.17],0.9869721674213237
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17592,118,1.29 [0.96-1.73],0.0864227968883751
